Development of real-time quantitative PCR assays requires suitable positive controls. For assays with clinical applications, these controls may be difficult to obtain because some molecular aberrations are rare and patient material may be available in limited amounts. Because of the risk of introducing contaminations in the laboratory, cloned DNA is not a desirable alternative. We describe the use of dU-containing DNA as a positive control template in real-time quantitative PCR. dU-DNA constructs can be decontaminated by adding uracil N-glycosylase (UNG) to the reaction mixture. In addition, dU-DNA can be used for accurate quantification, because it allows quantification to be expressed in numbers of molecules. Since synthetic dU-DNA constructs can easily be quantitated spectroscopically, they provide a more accurate control than arbitrary cell line units. We applied this method for the detection of the E2A-Pbx1 gene fusion and show that UNG-containing reactions can be employed for diagnostics without loss of sensitivity, and that for positive and quantitative controls UNG negative reactions can be used. The use of dU-DNA provides a novel type of control template that can easily be integrated into existing PCR protocols. Leukemia (2001Leukemia ( ) 15, 1962Leukemia ( -1965 
Introduction
In recent years, real-time PCR has become an increasingly important molecular biological tool in research, as well as in diagnostics. 1 Development of a real-time quantitative PCR assay requires a suitable positive control of which a dilution series is used to generate a quantitation curve. Occasionally, such a control is locally unavailable, hard to obtain, or in the case of patient samples not available in sufficient amounts. This applies especially to fusion genes derived from chromosomal translocations. For some translocations, multiple breakpoints occur in one or both of the genes involved, eg t(9;22) 1, 2 and inv(16). 3 Quantitation by real-time PCR requires a limited amplicon length (typically less than 300 bp), to ensure a high and reproducible PCR efficiency. Therefore, if the target gene has multiple breaking points separated by several hundreds of base pairs or more, multiple controls are required that result in approximately the same amplicon length as the analyzed samples for a comparable PCR efficiency and reliable quantitation. If a cell line or patient sample with a particular target sequence is not available, it will become necessary to use an artificial control template. The usual approach is to create a plasmid or vector with a cloned fusion gene construct. Alternatively, a DNA fragment with the desired sequence can be synthesized if the amplicon length allows for this. These methods have the disadvantage that contaminations are easily introduced and, given the sensitivity of PCR, may lead to unwanted false-positive results. For these reasons, many laboratories are reluctant to use these types of template as positive controls. This problem might be overcome by the use of synthetic DNA in which the deoxythymidine bases are replaced by deoxyuridine. As a result of this substitution, the DNA becomes sensitive to the activity of uracil N-glycosylase (UNG 4 ). UNG hydrolyses the N-glycosidic bond between the uracil base and the deoxyribose backbone, leading to stranddestabilizing abasic sites. Real-time PCR reaction mixtures usually contain deoxyuridine triphosphate instead of deoxythymidine triphosphate, as well as UNG. This results in the incorporation of the deoxyuridine in the PCR product. Possible carry-over contaminations with post-PCR product are then destroyed by incubating the PCR tubes at a temperature suitable for UNG activity before the start of the PCR. 5 Without the need for extra modifications to the PCR procedure, this aspect of the PCR can also be used in the protection against contaminations with a dU-based synthetic DNA template. For PCR development and calibration purposes, the UNG enzyme should not be included in the PCR mixture, leaving intact dU-DNA to serve as the PCR template. In the same series, in samples used for clinical decision-making, the enzyme could be added to the PCR mixture so template contaminations will not influence the results obtained.
We tested the use of a synthetic dU-based DNA template as a control for the development of a real-time PCR assay for the detection of the fusion gene of E2A (also known as TCF3 or ITF1) and Pbx1 (Prl). This translocation is the result of a t(1;19) chromosomal translocation and is associated with pre-B cell acute lymphoblastic leukemias (ALL).
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Materials and methods
The PCR and subsequent analyses were performed in the GeneAmp 7700 Sequence Detection System (Applied Biosystems). Real-time quantitation was performed using the Taqman technology of Applied Biosystems (Foster City, CA, USA). Primer and probe sequences (5Ј to 3Ј) were as follows: 119F2 -AGGCACCC TCCCTGACCT, 119R -TCCTGGGCT CCTCGGATACT, 119P -FAM-CGGCCTCCCGACTCCTA-CAGTGTTTT-TAMRA. The synthetic dU-containing DNA dU119 had the sequence AGGCACCCTCCCTGACCTGTCT CGGCCTCCCGACTCCTACAGTGTTTTGAGTATCCGAGGA GCCCAGGA. This sequence contains the primer and probe sequences (separated by bases that are underlined) and corresponds to the sequence of the fusion transcript at the breaking point between E2A and Pbx1.
PCR reactions were performed in duplicate using various amounts of dU119 DNA or cDNA derived from the t(1;19) containing 697 cell line. For the latter purpose, total RNA was isolated from 697 cells by cesium chloride centrifugation followed by reverse transcription as described. 1 The PCR reaction mixture contained 300 nm of both primers, 200 nm Taqman probe, and 1 × Taqman Universal Master Mix (Applied Biosystems) with or without 0.01 U/l AmpErase UNG. The reactions were first incubated at 50°C for 2 min to allow for the optional AmpErase activity to proceed. This was followed by 10 min at 95°C for activation of the DNA polymerase, as well as inactivation of the UNG and destruction of the digested dU-DNA. The PCR itself consisted of 40 cycles with 15 s at 95°C and 60 s at 60°C each. The fluorescence signal was measured during the last 30 s of the anneal/extension phase. After the PCR, a fluorescence threshold value was set and threshold cycles (Ct) values were determined, ie the fractional cycle at which the fluorescence signal reached this threshold. These values were used for further calculations.
Results and discussion
PCR validation
To determine the effect of UNG on the PCR efficiency, realtime quantitation was performed on a 10-fold serial cDNA dilution series derived from 50 ng of 697 cell line RNA in the presence or absence of UNG. Up to a 10 −4 dilution, the plot of the Ct value against the log of the number of template molecules present shows a linear correlation (Figure 1) . The relation between those values can be expressed as Ct = A log(N) + B, with A being the slope, N the starting quantity, and B the Y-intercept (ie the hypothetical Ct for N = 1). 8, 9 The slope A relates to the PCR efficiency E as A = −1/log(1+E). From the data shown in Figure 1 , the calculated slope A was −3.20 and −3.34 for the absence and presence of UNG,
Figure 1
Real-time amplification of a cell line cDNA dilution series is not affected by UNG. Real-time quantitative PCR and subsequent analyses were carried out as described in the text. Reactions containing various amounts of cDNA derived from the 697 cell line were performed in presence (open bars) or absence of uracil N-glycosylase (closed bars).
Leukemia respectively. This closely matches the value of −3.32 corresponding to a PCR efficiency of 100%. Based on these findings, we conclude that the reaction conditions are suitable for amplification of this target without further adjustments and that the UNG does not have any significant effect on the PCR efficiency.
Use of synthetic dU-DNA template
To validate the applicability of dU-based synthetic DNA, we carried out a real-time quantitative PCR using primers and probes described above and various amounts of dU119 template. To determine the efficiency of UNG in removing dU-DNA, this PCR was performed both with and without UNG in the reaction mixture. In the absence of UNG, the dU119 fragment could be detected down to 100 copies (Figure 2 ). For lower amounts, an amplification signal was obtained, but the Ct value was outside the linear range, so these values could not be used for quantitation. This time the value for the calculated slope was −3.22, indicating a maximally efficient PCR, thus proving the potential use of dU-DNA fragments as standards.
In the presence of UNG the number of template molecules at the start of the PCR depends on the action of the UNG enzyme. As has been shown, the PCR efficiency of the described protocol is the same in the presence or absence of UNG. Therefore, the differences in Ct value between conditions with and without UNG are not the result of differences in PCR performance, but can be ascribed solely to the degradation of dU-containing template by the UNG enzyme. Considering the above, it was calculated that in the presence of UNG, a template input of 3 × 10 6 is degraded to 2.5 × 10 2 molecules. Concentrations between 3 × 10 5 -3 × 10 2 dU-DNA molecules per reaction gave no quantitative signal. At these concentrations, the dU119 fragment was degraded to less than three copies and although some reactions showed amplification, the Ct value was not useful for quantitation purposes because it was outside the linear range. For less than 3 × 10 2 copies per reaction, no amplification signal was found, indicating complete dU119 degradation (Figure 2 ).
Figure 2
Real-time amplification of the synthetic dU-DNA fragment and its degradation by UNG. Real-time quantitative PCR and subsequent analyses were carried out as described in the text. Reactions containing indicated amounts of dU119 synthetic template were performed in presence (open bars) or absence of uracil N-glycosylase (closed bars). For 3.0E2 and 3.0E3 copies in the presence of UNG, only one of duplicate reactions yielded an amplification signal. For higher amounts both duplicates showed amplification, for lower amounts none.
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Quantitation is not affected by dU-DNA contaminations
As contaminations with dU-DNA, or indeed any positive control, can easily occur, it should be ascertained that they do not interfere with quantitation used for clinical decision-making. To meet the standards used in clinical diagnostics, a 10 −3 dilution (ie 50 pg) of cell line cDNA should be reliably detected without interference caused by possible dU-DNA contaminations. Using the data obtained with the dU119 fragment as a standard, it was calculated that 50 pg of 697 cDNA contains about 750 copies of the E2A-Pbx1 fusion gene transcript. A UNG-containing PCR assay was performed using 50 pg of 697 cDNA, 3.0 × 10 5 copies of dU119, or both. As is indicated in Figure 3 , this contamination with a 400-fold excess of synthetic DNA does not result in a significant change in Ct. Therefore, dU-based DNA can safely be used as a control without the risk of false-positive due to contaminations.
Advantages of dU-based template
Several molecular applications of synthetic DNA that contains deoxyuridine bases have been described. These include their use as PCR primers for nested PCR, 10 specific RNA amplification, 11 and adapter sequences for cloning. 12 Also, the use of dU-based DNA in site-directed mutagenesis has been described, 13, 14 as well as in labeling oligonucleotide probes. 15 We describe a novel use of dU-containing DNA, namely as a degradable template in PCR quantitation. This type of PCR template may offer several advantages compared to other control templates. An important benefit of a synthetic template is the possibility to use this in a PCR if a suitable control is lacking because a particular sequence is rare. This includes some fusion genes derived from chromosomal translocations, as well as allelic variants of more common genes. In addition, it is possible to generate synthetic fusion sequences that can be expected to exist on theoretical grounds, but have not yet been discovered in clinical specimens. A great advantage of using dU-based DNA instead of cloned DNA for these cases, is its degradability. The risk of contaminations leading to falsepositive results can be virtually eliminated by adding UNG to the reaction mixture. Since false positives are a serious practical problem in many molecular diagnostic laboratories, this procedure could offer a solution. As can be deduced from Figure 2 , the AmpErase activity degrades up to 10 5 molecules of dU-DNA. Carry-over contaminations with larger amounts of template are unlikely. Furthermore, the use of dU-DNA allows for a precise quantification of the amount of template used in the PCR reaction, eg for resolving the lower limit of detection. Amounts of synthetic DNA can be quantitated spectroscopically. Therefore, quantitation can be expressed in the number of template molecules, rather than arbitrary units based on a variable cell line or the relative expression of an endogenous control. This is not only more constant, but also gives more insight into the actual levels of the target transcript studied. In addition, the integrity of the template can be easily verified by gel or capillary electrophoresis. New batches of dU-DNA can easily and reproducibly be synthesized, allowing these constructs to be used reliably throughout time and facilitating inter-laboratory comparisons.
The use of dU-containing DNA can be integrated into existing PCR protocols without significant changes. For a typical quantitative analysis, the calibration series should contain various amounts of dU-DNA in the absence of UNG. A UNGcontaining control should be carried out to verify the activity of this enzyme. This reaction should contain a number of dUbased template molecules that would give a clear signal in the absence of UNG, but none in its presence. For the PCR described here 10 5 molecules would be a suitable input. Finally, to destroy contaminations with dU-DNA, UNG is required in the PCR reactions for the samples under study, as well as the non-template control. In conclusion, we show that synthetic dU-containing DNA provides a novel type of control template that can easily be integrated into current PCR protocols.
